Literature DB >> 2984303

Regulation of macrophage lysosomal secretion by adenosine, adenosine phosphate esters, and related structural analogues of adenosine.

D W Riches, J L Watkins, P M Henson, D R Stanworth.   

Abstract

Zymosan particle-stimulated beta-galactosidase secretion by mouse peritoneal macrophages was found to be inhibited by micromolar concentrations of adenosine, AMP, ADP, and ATP. Inhibition by all four agents was increased to approximately 80% by adding erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA; 10 microM) an adenosine deaminase inhibitor, to the incubation medium. The inhibition of lysosomal enzyme secretion by ATP, ADP, and AMP was reversed by adding alpha, beta -methylene ADP (100 microM), a 5'-nucleotidase inhibitor, to the incubation medium. Inhibition by adenosine, however, was unaffected by alpha, beta -methylene ADP indicating that the inhibition by AMP, ADP, and ATP only occurred after they had been converted to adenosine by cell surface phosphohydrolases, including 5'-nucleotidase. Theophylline, a competitive antagonist of the binding of adenosine to plasma membrane adenosine receptors, failed to reverse the inhibitory effect of adenosine indicating the probable site of adenosine action to be intracellular. Other purine nucleosides, e.g., guanosine, and several purine and ribosemodified structural analogues of adenosine also inhibited zymosan-stimulated beta-galactosidase secretion, while xanthosine and certain pyrimidine nucleosides, e.g., thymidine, were inactive in this respect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984303     DOI: 10.1002/jlb.37.5.545

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  10 in total

Review 1.  Recent aspects of gonadal hormone and neurotransmitter interactions with synovial and immune cells: implications in rheumatoid arthritis.

Authors:  M Cutolo; R H Straub
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

2.  Preferential inhibition of primary granule release from bovine neutrophils by a Brucella abortus extract.

Authors:  T A Bertram; P C Canning; J A Roth
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

3.  Identification of suppressive components in "Haemophilus somnus" fractions which inhibit bovine polymorphonuclear leukocyte function.

Authors:  Y W Chiang; M L Kaeberle; J A Roth
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  "Haemophilus somnus," a facultative intracellular pathogen of bovine mononuclear phagocytes.

Authors:  J A Lederer; J F Brown; C J Czuprynski
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

5.  Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.

Authors:  B N Cronstein; M A Eberle; H E Gruber; R I Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Characterization of a phosphomonoesterase from Brucella abortus.

Authors:  A K Saha; N K Mukhopadhyay; J N Dowling; T A Ficht; L G Adams; R H Glew
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages.

Authors:  E S Drazek; H S Houng; R M Crawford; T L Hadfield; D L Hoover; R L Warren
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Reduction of postischemic leukocyte-endothelium interaction by adenosine via A2 receptor.

Authors:  D Nolte; A Lorenzen; H A Lehr; F J Zimmer; K N Klotz; K Messmer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-08       Impact factor: 3.000

9.  Schistosome tegumental ecto-apyrase (SmATPDase1) degrades exogenous pro-inflammatory and pro-thrombotic nucleotides.

Authors:  Akram A Da'dara; Rita Bhardwaj; Yasser B M Ali; Patrick J Skelly
Journal:  PeerJ       Date:  2014-03-18       Impact factor: 2.984

Review 10.  Purinergic signalling and immune cells.

Authors:  Geoffrey Burnstock; Jean-Marie Boeynaems
Journal:  Purinergic Signal       Date:  2014-10-29       Impact factor: 3.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.